Shares of Scilex Holding (NASDAQ:SCLXW – Get Free Report) rose 22% on Wednesday . The company traded as high as $0.11 and last traded at $0.11. Approximately 369 shares were traded during trading, a decline of 96% from the average daily volume of 9,118 shares. The stock had previously closed at $0.09.
Scilex Stock Up 22.0 %
The company’s 50 day moving average price is $0.21 and its two-hundred day moving average price is $0.26.
About Scilex
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
Further Reading
- Five stocks we like better than Scilex
- How to Calculate Return on Investment (ROI)
- Buffett’s on the Sidelines – Should You Follow?
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- What is a Dividend King?
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Scilex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scilex and related companies with MarketBeat.com's FREE daily email newsletter.
